Shay Capital »

Context Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $116k 190k 0.61
2024-12-31 $53k 50k 1.05

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Ftai Aviation SHS (FTAI)
Vor Biopharma Com New Call Option
Sable Offshore Corp Com Shs (SOC)
First Solar (FSLR)
Tesla Motors (TSLA)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads (BABA)
Agnc Invt Corp Com reit (AGNC)
Jd.com Spon Ads Cl A (JD)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Shay Capital

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Avidity Partners Management
Deep Track Capital
Nextech Invest
Blue Owl Capital Holdings
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Vanguard Group
Blackstone Group
Alyeska Investment Group
Nantahala Capital Management
Sio Capital Management
BlackRock
Geode Capital Management
Affinity Asset Advisors

View all funds holding Context Therapeutics